Biden administration to invest $1.7B to identify, track coronavirus variants

The Biden administration says the U.S. is setting up a $1.7 billion national network to identify and track worrisome coronavirus mutations whose spread could trigger another pandemic wave.

Pfizer CEO says third dose of vaccine 'likely' needed within 1 year

The CEO of pharmaceutical giant Pfizer said during a televised interview Thursday that people will "likely" need a third dose of the COVID-19 vaccine.

Twin brother pharmacists help vaccinate North Texans

Pharmacists Kenny and Chino Agbasi say they are reminded why they were drawn to patient care in the first place.

Lack of vaccines in other parts of world puts US at risk, could prolong pandemic, experts say

Dr. Anthony Fauci, the nation’s leading expert on infectious diseases, said the longer the novel coronavirus is allowed to replicate in any part of the world, the more opportunity new variants have to emerge and threaten the country’s chance of reaching herd immunity.

US opens more distance in worldwide race against COVID-19 as it nears 200M vaccines administered

Nearly half of American adults have gotten at least one dose of the vaccine, and about 30% have been fully vaccinated. But the picture is still relentlessly grim in parts of Europe, Latin America, Africa and Asia.

Most kids with MIS-C had mild COVID-19, some also developed neurological symptoms, research shows

New research has found that most kids with a serious inflammatory illness linked to the coronavirus had no COVID-19 symptoms or just mild ones. Another small study found that many MIS-C patients also suffered neurological symptoms.

Pollen could play role increased COVID-19 infection rates, study suggests

The spring season correlates with increased pollen counts, and according to a new study, the common allergen could be making COVID-19 infection rates worse.

J&J COVID-19 vaccine pause to remain in place while officials seek more evidence on rare clots

The pause on Johnson & Johnson’s COVID-19 vaccine will remain in place for now after U.S. health advisers said they need more evidence to make any decision about the rare blood clots reported.

NFL says more than 2M COVID-19 vaccines administered at its stadiums

The NFL announced Wednesday that more than 2 million COVID-19 vaccinations have been administered at its stadiums and facilities since starting the campaign earlier this year.

Johnson & Johnson pauses COVID-19 vaccine trial after US recommends investigation of rare clotting reports

Johnson & Johnson said it will pause an ongoing trial of its COVID-19 vaccine after federal health officials recommended the action in the wake of six reported U.S. cases of a rare type of blood clotting following vaccination.

Moderna says its COVID-19 vaccine greater than 90% effective against virus 6 months after second shot

Moderna said its latest Phase 3 clinical trial found that its vaccine remains greater than 90% effective against COVID-19, and greater than 95% effective against severe cases of COVID-19, six months after the second dose.

Dallas, Tarrant counties pause use of Johnson & Johnson shots over safety concerns

Concerns about a rare side effect of the Johnson & Johnson COVID-19 vaccine forced North Texas providers to either cancel or redirect their vaccination efforts.